LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Reduction of low density lipoprotein-cholesterol and cardiovascular events with proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors and statins: an analysis of FOURIER, SPIRE, and the Cholesterol Treatment Trialists Collaboration

Photo from wikipedia

Division of Translational Research and Clinical Epidemiology, Division of Cardiovascular Medicine, Wayne State University School of Medicine, Detroit, MI, USA; Cardiovascular Division, Brigham and Women’s Hospital, Boston, MA, USA; Department… Click to show full abstract

Division of Translational Research and Clinical Epidemiology, Division of Cardiovascular Medicine, Wayne State University School of Medicine, Detroit, MI, USA; Cardiovascular Division, Brigham and Women’s Hospital, Boston, MA, USA; Department of Cardiology, Charite Universit€ats Medizin Berlin, Campus Benjamin Franklin, Berlin, Germany; Department of Cardiology, University Heart Center, University Hospital Zurich, Switzerland; Department of Pharmacological and Biomolecular Sciences, MultiMedica Istituto di Ricovero e Cura a Carattere Scientifico, University of Milan, Via Balzaretti, 9, 20133 Milan, Italy; and Imperial Centre for Cardiovascular Disease Prevention, Department of Primary Care and Public Health, School of Public Health, Imperial College, London, UK

Keywords: medicine; reduction low; cardiology; cholesterol; university; department

Journal Title: European Heart Journal
Year Published: 2018

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.